Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01461824

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:57.000682+00:00

Published At

2018-04-23T00:00:00+00:00

Record Updated At

2018-04-23

Results Posted At

2018-04-23

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Weight Gain", "Disorder of Bone Density and Structure, Unspecified", "Uterine Bleeding"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-04-23"

protocolSection.identificationModule.nctId

"NCT01461824"

protocolSection.identificationModule.officialTitle

"Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-04-23"

Study condition terms

• Weight Gain (protocolSection.conditionsModule.conditions)
• Disorder of Bone Density and Structure, Unspecified (protocolSection.conditionsModule.conditions)
• Uterine Bleeding (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.